LGM
ANAB icon

Logos Global Management’s AnaptysBio ANAB Stock Holding History

Logos Global Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-250,000
Closed -$7.75M – 44
2022
Q4 		$7.75M Buy
+250,000
New +$7.06M 0.91% 30
2022
Q2 		– Sell
-300,000
Closed -$7.42M – 33
2022
Q1 		$7.42M Buy
+300,000
New +$9.08M 0.96% 25

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Logos Global Management's ANAB Position: Q1 2023 in Review

Logos Global Management sold out of AnaptysBio (ANAB) in Q1 2023, closing a stake of 250,000 shares — an estimated $7.75M sold.

Logos Global Management first reported a position in ANAB in Q1 2022 and held it in 2 quarters. The position peaked at $7.75M in Q4 2022. 113 funds tracked by Wall St. Rank hold ANAB as of Q1 2023.

  • Logos Global Management reported no remaining AnaptysBio position as of Q1 2023 after selling out during the quarter.
  • Logos Global Management sold 250,000 AnaptysBio shares in Q1 2023, an estimated $7.75M.
  • Logos Global Management first reported a position in AnaptysBio in Q1 2022 and held it in 2 quarters.
  • Logos Global Management's AnaptysBio position peaked at $7.75M in Q4 2022.
  • 113 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2023.

Based on Logos Global Management's 13F filing for Q1 2023, filed 15 May 2023.